Non‐invasive cell‐free fetal DNA testing for aneuploidy: multicenter study of 31 515 singleton pregnancies in southeastern China
暂无分享,去创建一个
N. Lin | D. He | Hailong Huang | Liangpu Xu | Yan Wang | Lingji Chen | Meihuan Chen | Min Zhang | Yuan Lin | Liangpu Xu
[1] F. Yu,et al. Clinical utility of noninvasive prenatal screening for expanded chromosome disease syndromes , 2019, Genetics in Medicine.
[2] B. Levy,et al. Traditional Prenatal Diagnosis: Past to Present. , 2018, Methods in molecular biology.
[3] L. Hui. Noninvasive Approaches to Prenatal Diagnosis: Historical Perspective and Future Directions. , 2018, Methods in molecular biology.
[4] S. Phelan,et al. Delivering the Diagnosis of Sex Chromosome Aneuploidy: Experiences and Preferences of Parents and Individuals , 2018, Clinical pediatrics.
[5] A. Caughey,et al. How should costs and cost-effectiveness be considered in prenatal genetic testing? , 2018, Seminars in perinatology.
[6] Zhengfeng Xu,et al. Perinatal outcomes following cell‐free DNA screening in >32 000 women: Clinical follow‐up data from a single tertiary center , 2018, Prenatal diagnosis.
[7] S. Y. Kim,et al. Prospective observations study protocol to investigate cost-effectiveness of various prenatal test strategies after the introduction of noninvasive prenatal testing , 2018, BMC Pregnancy and Childbirth.
[8] P. Serrano-Aguilar,et al. Cost-effectiveness of cell-free DNA in maternal blood testing for prenatal detection of trisomy 21, 18 and 13: a systematic review , 2018, The European Journal of Health Economics.
[9] D. Deng,et al. New medical risks affecting obstetrics after implementation of the two-child policy in China , 2017, Frontiers of Medicine.
[10] A. Breman,et al. Positive predictive value estimates for cell‐free noninvasive prenatal screening from data of a large referral genetic diagnostic laboratory , 2017, American journal of obstetrics and gynecology.
[11] R. Kirby. The prevalence of selected major birth defects in the United States. , 2017, Seminars in perinatology.
[12] M. Plana,et al. Analysis of cell‐free DNA in maternal blood in screening for aneuploidies: updated meta‐analysis , 2017, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.
[13] V. Cirigliano,et al. Screening for Sex Chromosome Aneuploidy by Cell-Free DNA Testing: Patient Choice and Performance , 2017, Fetal Diagnosis and Therapy.
[14] N. Vora,et al. Prenatal Diagnosis: Screening and Diagnostic Tools. , 2017, Obstetrics and gynecology clinics of North America.
[15] Lorenzo D Botto,et al. Etiology and clinical presentation of birth defects: population based study , 2017, British Medical Journal.
[16] P. Opara,et al. Prevalence and pattern of birth defects in a tertiary health facility in the Niger Delta area of Nigeria , 2017, International journal of women's health.
[17] E. Bernabé,et al. Analysis of cell‐free fetal DNA in maternal blood for detection of trisomy 21, 18 and 13 in a general pregnant population and in a high risk population – a systematic review and meta‐analysis , 2017, Acta obstetricia et gynecologica Scandinavica.
[18] R. Morris,et al. The accuracy of cell‐free fetal DNA‐based non‐invasive prenatal testing in singleton pregnancies: a systematic review and bivariate meta‐analysis , 2017, BJOG : an international journal of obstetrics and gynaecology.
[19] Y. Takwoingi,et al. Genomics-based non-invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women. , 2015, The Cochrane database of systematic reviews.
[20] C. Chung,et al. Clinical Experience of Non-Invasive Prenatal Chromosomal Aneuploidy Testing in 190,277 Patient Samples. , 2016, Current molecular medicine.
[21] D. Cram,et al. Copy number variation sequencing‐based prenatal diagnosis using cell‐free fetal DNA in amniotic fluid , 2016, Prenatal diagnosis.
[22] A. Latos-Bieleńska,et al. Cell-Free DNA Analysis of Targeted Genomic Regions in Maternal Plasma for Non-Invasive Prenatal Testing of Trisomy 21, Trisomy 18, Trisomy 13, and Fetal Sex. , 2016, Clinical chemistry.
[23] Aileen Clarke,et al. Accuracy of non-invasive prenatal testing using cell-free DNA for detection of Down, Edwards and Patau syndromes: a systematic review and meta-analysis , 2016, BMJ Open.
[24] R. Stokowski,et al. Clinical performance of non‐invasive prenatal testing (NIPT) using targeted cell‐free DNA analysis in maternal plasma with microarrays or next generation sequencing (NGS) is consistent across multiple controlled clinical studies , 2015, Prenatal diagnosis.
[25] L. Dugoff,et al. Position statement from the Chromosome Abnormality Screening Committee on behalf of the Board of the International Society for Prenatal Diagnosis , 2015, Prenatal diagnosis.
[26] J. Hornberger,et al. An Economic Analysis of Cell-Free DNA Non-Invasive Prenatal Testing in the US General Pregnancy Population , 2015, PloS one.
[27] Y. Gao,et al. Non‐invasive prenatal testing for trisomies 21, 18 and 13: clinical experience from 146 958 pregnancies , 2015, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.
[28] T. Musci,et al. Cell-free DNA analysis for noninvasive examination of trisomy. , 2015, The New England journal of medicine.
[29] E. Hardisty,et al. Advances in genetic prenatal diagnosis and screening , 2014, Current opinion in pediatrics.
[30] S. Carmichael. Birth defects epidemiology. , 2014, European journal of medical genetics.
[31] R. Rava,et al. DNA sequencing versus standard prenatal aneuploidy screening. , 2014, The New England journal of medicine.
[32] M. Rochon. DNA Sequencing Versus Standard Prenatal Aneuploidy Screening , 2014 .
[33] Yijun Song,et al. Noninvasive prenatal testing of fetal aneuploidies by massively parallel sequencing in a prospective Chinese population , 2013, Prenatal diagnosis.
[34] D. Liang,et al. Non‐invasive prenatal testing of fetal whole chromosome aneuploidy by massively parallel sequencing , 2013, Prenatal diagnosis.
[35] X. Bian,et al. Current situation and development of prenatal diagnosis in China , 2010, Frontiers of medicine in China.
[36] Yingyao Chen,et al. Situation analysis of prenatal diagnosis technology utilization in China: Current situation, main issues, and policy implications , 2004, International Journal of Technology Assessment in Health Care.
[37] I. Sargent,et al. Presence of fetal DNA in maternal plasma and serum , 1997, The Lancet.